New diet drugs are new versions of old off-label treatments

General Health
The Wall Street Journal reports that although some doctors who treat obesity patients hailed the FDA's recent approval of Qsymia and Belviq – the agency's first diet-drug approvals in more than a decade – as an advancement in weight-loss treatment, many weight-loss specialists have been prescribing variations of the two drugs off-label for the past 10 years. (more…)
Read More

Group recommends against ECG for low-risk patients

General Health
The Wall Street Journal reports that the US Preventive Services Task Force (USPSTF) announced that individuals who face a low risk of cardiovascular disease should NOT undergo routine screening with electrocardiography (ECG). This makes sense to me. In over 30 years of practice, I can think of NO routine EKG in a low-risk patient, at least during an annual health-maintenence or preventive medicine exam, that has changed my treatment plan or therapy. (more…)
Read More